DEA has released the complete 2,533 page transcript from 11 days of federal cannabis rescheduling hearings as the administrative law judge prepares a recommendation. The record moves the process closer to a decision while operators continue facing uncertainty around 280E, federal compliance, medical cannabis strategy, research, and investment timing.

U.S. Eagle Federal Credit Union is leaving cannabis banking in New Mexico after seven years, citing increased competition rather than weak demand. The exit shows how mature cannabis markets are shifting from basic banking scarcity toward competition around service, compliance, cash management, lending, and financial strategy.

Canada remains the world's largest medical cannabis exporter, but growing European production is beginning to challenge its lead. Germany's expanding market, Portugal's rapid export growth, stricter pharmaceutical standards, reimbursement changes, and new lower cost suppliers are reshaping international cannabis competition.

FDA still has not published congressionally required cannabinoid lists and container guidance as major federal hemp restrictions approach. The delay leaves manufacturers and retailers facing uncertainty around reformulation, packaging, potency, inventory, product classification, and compliance before the November 12 transition.

Canada still supplies most of Australia's imported medical cannabis, but Thailand rapidly gained market share in 2025 while Australian domestic production reached a new high. The shift shows an increasingly competitive supply chain where pricing, quality standards, contracts, inventory, and reliable international market access matter more.

Missouri received nearly 900 applications for 77 licenses in its final cannabis microbusiness round, with the lottery scheduled for September 9. New ownership and vetting rules mean selection alone will not guarantee a license, increasing pressure around control, financing, compliance, and post selection readiness.